- Conditions: Aging; Mild Cognitive Impairment; Angina Pectoris
Intervention:
Sponsors: Korea Institute of Oriental Medicine; Korea Institute of Oriental Medicine; Dunsan Oriental Medical Hospital of Daejeon University
Recruiting - verified May 2012 - Conditions: Coronary Artery Disease; Myocardial Ischemia
Intervention:
Sponsors: Biotronik Vertriebs-GmbH; Biotronik Vertriebs-GmbH
Recruiting - verified May 2012 - Condition: Angina Pectoris
Interventions: Drug: Rosuvastatin; Drug: Placebo.
Sponsors: Oslo University Hospital; Oslo University Hospital
Not yet recruiting - verified April 2012 - Condition: Acute Coronary Syndrome
Intervention:
Sponsors: Yokohama City University Medical Center; Yokohama City University Medical Center
Recruiting - verified April 2012 - Condition: Refractory Angina
Intervention: Device: Neovac coronary sinus reducer
Sponsors: Tel-Aviv Sourasky Medical Center; Tel-Aviv Sourasky Medical Center; Neovasc Inc.
Not yet recruiting - verified March 2012 - Conditions: Acute Coronary Syndrome; Myocardial Infarction
Interventions: Drug: Clopidogrel; Drug: Placebo
Sponsors: Campus Bio-Medico University; Campus Bio-Medico University
Recruiting - verified April 2012 - Conditions: Chronic Stable Angina; Coronary Artery Disease; Atrial Fibrillation; Ventricular Tachycardia
Interventions: Drug: ranolazine; Drug: placebo
Sponsors: Cardiovascular Consultants of Nevada; Cardiovascular Consultants of Nevada; Gilead Sciences
Recruiting - verified March 2012 - Conditions: Stable Angina; Unstable Angina; Acute Myocardial Infarction
Intervention: Device: Amphilimus Eluting Stent (CRE8)
Sponsors: CID - Carbostent & Implantable Devices; CID - Carbostent & Implantable Devices
Recruiting - verified March 2012 - Condition: Stable Angina
Intervention:
Sponsors: Medtronic Vascular; Medtronic Vascular
Recruiting - verified April 2012 - Condition: Atherosclerotic Coronary Vascular Disease
Intervention: Other: Ranolazine
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified March 2012 - Condition: Angina
Interventions: Drug: Febuxostat; Drug: Placebo
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.
Recruiting - verified April 2012 - Conditions: Chest Pain; Myocardial Infarction; Acute Coronary Syndrome; Coronary Artery Disease; Myocardial Ischemia
Interventions: Other: Cardiovascular Magnetic Resonance Imaging; Other: Computed Tomography Angiography
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center; Dutch Heart Foundation
Recruiting - verified April 2012 - Condition: Angina, Stable
Intervention: Genetic: Alferminogene tadenovec
Sponsors: Cardium Therapeutics; Cardium Therapeutics; Advanced Biosciences Research
Recruiting - verified March 2012 - Conditions: Coronary Artery Disease; Acute Coronary Syndrome
Interventions: Other: [18F]-FDG positron emission computed tomography; Procedure: Invasive coronary angiography; Procedure: Intravascular ultrasound and virtual histology; Other: Serum biomarkers
Sponsors: Ludwig-Maximilians - University of Munich; Ludwig-Maximilians - University of Munich
Not yet recruiting - verified March 2012 - Conditions: Coronary Artery Disease; Stable Angina; Unstable Angina; NSTEMI
Interventions: Device: Drug eluting balloon + Bare metal stent; Device: drug eluting stent (Zotarolimus-eluting stent)
Sponsors: Seoul National University Bundang Hospital; Seoul National University Bundang Hospital
Recruiting - verified February 2012 - Conditions: Stable Angina; Unstable Angina; NSTEMI
Interventions: Device: Amphilimus Eluting Stent; Device: Bare Metal Stent
Sponsors: CID - Carbostent & Implantable Devices; CID - Carbostent & Implantable Devices
Recruiting - verified February 2012 - Condition: Acute Coronary Syndrome
Interventions: Drug: Modification of Prasugrel based on a biological assay; Drug: prasugrel / clopidogrel; Device: Verify Now
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris; Eli Lilly and Company; Daiichi Sankyo Inc.; Allies in Cardiovascular Trials Initiatives and Organized Networks:ACTION; Accumetrics, Inc.; Stentys
Not yet recruiting - verified February 2012 - Condition: Coronary Artery Disease
Interventions: Drug: Clopidogrel; Drug: Prasugrel; Drug: Ticagrelor
Sponsors: University of Roma La Sapienza; University of Roma La Sapienza
Not yet recruiting - verified March 2012 - Condition: Acute Coronary Syndrome
Interventions: Drug: Clopidogrel; Drug: prasugrel
Sponsors: University of Roma La Sapienza; Gennaro Sardella
Recruiting - verified February 2012 - Conditions: Myocardial Infarction; Acute Coronary Syndromes; Unstable Angina
Interventions: Drug: Tirofiban; Drug: Eptifibatide
Sponsors: Medicure; Medicure; Sarah Cannon Research Institute
Recruiting - verified May 2012 - Conditions: Coronary Artery Disease; Behavioral
Intervention:
Sponsors: University of Arizona; Richard Lane; University of Rochester
Recruiting - verified February 2012 - Conditions: Carotid Artery Disease; Stroke; Myocardial Infarction; Angina Pectoris
Intervention:
Sponsors: University of Athens; University of Athens
Recruiting - verified January 2012 - Condition: Acute Coronary Syndromes
Interventions: Drug: Everolimus; Drug: Placebo
Sponsors: University of Zurich; University of Zurich; Swiss National Science Foundation; Novartis
Not yet recruiting - verified February 2012 - Conditions: Acute Coronary Syndrome; Myocardial Ischemia; Acute Myocardial Infarction: Rehabilitation Phase
Intervention: Behavioral: Shared Care model
Sponsors: University of Aarhus; University of Aarhus; Region MidtJylland, Denmark.
Recruiting - verified February 2012 - Conditions: Chronic Myocardial Ischemia; Refractory Angina Pectoris; (Advanced) Coronary Heart Disease
Interventions: Biological: Auto-CD34+ cells; Biological: Placebo: Diluent used to suspend Auto-CD34+ cells; Other: Standard of care
Sponsors: Baxter Healthcare Corporation; Baxter Healthcare Corporation
Recruiting - verified April 2012 - Condition: Acute Coronary Syndrome
Interventions: Drug: LC23-1306; Drug: placebo; Drug: Ticagrelor
Sponsors: LG Life Sciences; LG Life Sciences
Recruiting - verified April 2012 - Conditions: Angina Pectoris; Myocardial Infarction; Coronary Disease; Myocardial Ischemia; Acute Coronary Syndrome
Intervention: Biological: MULTIGENE SCREENING FOR SINGLE SNPS
Sponsors: National Research Council, Italy; National Research Council, Italy; Italy, Public University for Education and Research (MIUR)
Recruiting - verified January 2012 - Conditions: Coronary Artery Stenosis; Coronary Heart Disease
Interventions: Drug: Quick-Acting Heart Reliever; Drug: Isosorbide Dinitrate; Drug: Placebo of Isosorbide Dinitrate; Drug: Aspirin Enteric-coated Tablets; Drug: Placebo of Quick-Acting Heart Reliever; Drug: Aspirin Enteric-coated Tablets
Sponsors: Guang'anmen Hospital of China Academy of Chinese Medical Sciences; Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Recruiting - verified January 2012 - Condition: Stable Angina or Acute Coronary Syndrome Considered for Percutaneous Coronary Intervention With Dyslipidemia or Hypertension
Interventions: Device: Sirolimus-eluting stent; Device: Biolimus-eluting stents; Drug: pravastatin 20mg/day after DES implantation; Drug: pitavastatin 2mg/day after DES implantation; Drug: Non-ARB /day after DES implantation; Drug: Eposartan 600mg/day after DES implantation
Sponsors: Yonsei University; Yonsei University
Recruiting - verified January 2012 - Conditions: Tako-TSUBO Cardiomyopathy; Acute Coronary Syndrome
Intervention:
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris; Fédération Française de Cardiologie
Recruiting - verified November 2011 - Condition: Acute Coronary Syndrome
Intervention: Procedure: PCI
Sponsors: Samara Regional Cardiology Dispensary; Samara Regional Cardiology Dispensary
Not yet recruiting - verified January 2012 - Condition: Coronary Artery Disease
Interventions: Drug: Ranolazine; Drug: Placebo
Sponsors: University of Roma La Sapienza; University of Roma La Sapienza
Not yet recruiting - verified December 2011 - Condition: Cardiovascular Diseases
Interventions: Drug: AMR101; Drug: Placebo
Sponsors: Amarin Pharma Inc.; Amarin Pharma Inc.
Recruiting - verified March 2012 - Condition: Acute Coronary Syndrome
Intervention:
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Condition: Angina Pectoris
Intervention:
Sponsors: Aalborg Hospital; Aalborg Hospital; Aalborg University
Not yet recruiting - verified November 2011 - Condition: Acute Coronary Syndrome
Interventions: Drug: Pre-procedural High dose atorvastatin loading; Drug: No pre-procedural high-dose atorvastatin loading
Sponsors: The Korean Society of Circulation; The Korean Society of Circulation
Recruiting - verified December 2011 - Condition: Acute Coronary Syndrome
Interventions: Other: EndoPAT testing (non invasive device); Other: WatchPAT testing (non-invasive device)
Sponsors: Mayo Clinic; Mayo Clinic; Qatar National Research Fund
Recruiting - verified December 2011 - Condition: Non ST Segment Elevation MI and Unstable Angina
Interventions: Procedure: One-Stage group; Procedure: Multi-Staged group
Sponsors: University of Roma La Sapienza; Gennaro Sardella
Recruiting - verified November 2011 - Condition: Coronary Artery Disease
Interventions: Drug: Bivalirudin; Drug: Heparin
Sponsors: Stony Brook University; Stony Brook University
Recruiting - verified October 2011 - Condition: Chronic Stable Angina
Interventions: Drug: Allopurinol; Drug: Allopurinol; Drug: Placebo
Sponsors: University of Dundee; Stephen McSwiggan; British Heart Foundation
Recruiting - verified April 2012 - Conditions: Acute Coronary Syndrome; Coronary Angioplasty
Interventions: Drug: Oral P2Y12 receptor blocker; Drug: Customized choice for the oral P2Y12 receptor blocker
Sponsors: Italian Society of Invasive Cardiology; Italian Society of Invasive Cardiology; Eustrategy
Recruiting - verified January 2012 - Condition: Acute Myocardial Infarction
Intervention: Behavioral: Discharge home
Sponsors: Charite University, Berlin, Germany; Charite University, Berlin, Germany; Kerckhoff-Klinik Bad Nauheim; University of Heidelberg; Universitätsklinikum Hamburg-Eppendorf
Recruiting - verified December 2011 - Condition: Stable Angina Pectoris
Interventions: Drug: Total Flavonoids of Propolis dropping pill; Drug: total Flavonoids of Propolis dropping pill
Sponsors: Shanghai Greenvalley Pharmaceutical Co., Ltd.; Shanghai Greenvalley Pharmaceutical Co., Ltd.
Not yet recruiting - verified March 2012 - Condition: Coronary Artery Disease
Interventions: Other: CT coronary angiography; Other: Standard of Care
Sponsors: Wellington Hospital; AJAY YERRAMASU; Wellington Hospital, London, UK; Barnet Hospital, Wellhouse Lane, Barnet, EN5 3DJ, UK; Chase Farm Hospital, The Ridgeway, Enfield, EN2 8JL, UK; Royal Free Hospital, Pond Street, London, NW3 2QG, UK
Recruiting - verified October 2011 - Condition: Coronary Artery Disease
Interventions: Procedure: Filtrap™ + Thrombus aspiration catheter; Procedure: Thrombus aspiration catheter
Sponsors: Yokohama City University Medical Center; Yokohama City University Medical Center; Teikyo University
Not yet recruiting - verified February 2012 - Conditions: Cardiovascular Diseases; Acute Coronary Syndrome
Interventions: Drug: clopidogrel; Drug: prasugrel
Sponsors: University of Maryland; University of Maryland; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified February 2012 - Condition: Variant Angina
Intervention: Drug: Placebo
Sponsors: Korea Otsuka Pharmaceutical Co.,Ltd.; Korea Otsuka Pharmaceutical Co.,Ltd.
Recruiting - verified January 2012 - Conditions: Cardiovascular Complications; Myocardial Infarction; Acute Coronary Syndromes
Intervention:
Sponsors: University of Sao Paulo; University of Sao Paulo; Fundação de Amparo à Pesquisa do Estado de São Paulo
Recruiting - verified October 2011 - Condition: Acute Coronary Syndrome
Interventions: Drug: Atorvastatin; Drug: Placebo
Sponsors: Hospital do Coracao; Hospital do Coracao; Ministry of Health, Brazil
Not yet recruiting - verified February 2012 - Conditions: Coronary Artery Disease; Angina Pectoris
Interventions: Drug: Ranolazine; Drug: Placebo
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified April 2012 - Conditions: Coronary Artery Disease; Angina Pectoris; Myocardial Infarction
Interventions: Device: Sirolimus-eluting stent with a bioresorbable polymer (Orsiro); Device: Everolimus-eluting stent with a durable polymer
Sponsors: University Hospital Inselspital, Berne; University Hospital Inselspital, Berne; Biotronik AG
Recruiting - verified April 2012 - Condition: Acute Coronary Syndrome
Intervention: Device: iMAP
Sponsors: Federal University of São Paulo; Federal University of São Paulo; Boston Scientific Corporation
Recruiting - verified September 2011 - Conditions: Acute Coronary Syndromes; STEMI; NSTEMI
Interventions: Other: trans-radial and short-term bivalirudin; Other: trans-radial and long-term bivalirudin infusion; Other: trans-radial and standard of care pharmacology; Other: Trans-femoral and Short-term bivalirudin; Other: trans-femoral and long-term bivalirudin infusion; Other: trans-femoral and standard of care pharmacology
Sponsors: Italian Society of Invasive Cardiology; Italian Society of Invasive Cardiology; Eustrategy
Recruiting - verified May 2012 - Conditions: Myocardial Infarction; Angina Pectoris; Stroke; Peripheral Arterial Disease
Intervention:
Sponsors: Jordi Gol i Gurina Foundation; Jordi Gol i Gurina Foundation; Preventive Services and Health Promotion Research Network
Recruiting - verified September 2011 - Condition: Angina Exacerbation Acute
Intervention:
Sponsors: Aerotel Ltd; Aerotel Ltd; Sheba Medical Center
Not yet recruiting - verified August 2011 - Conditions: Angina Pectoris; Coronary Artery Disease; Type 2 Diabetes Mellitus
Intervention: Drug: Ranolazine
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified March 2012 - Condition: Coronary Artery Disease
Intervention: Device: Fortify ST
Sponsors: St. Jude Medical; St. Jude Medical
Recruiting - verified October 2011 - Conditions: Coronary Heart Disease; Angina; Hemodialysis
Interventions: Drug: Ivabradine; Drug: Carvedilol
Sponsors: Second University of Naples; Second University of Naples; IRCCS San Raffaele
Recruiting - verified August 2011 - Condition: Angina
Interventions: Drug: Nasal oxygen; Drug: Regular nasal air
Sponsors: Region Skane; Region Skane
Recruiting - verified August 2011 - Condition: Acute Coronary Syndromes
Interventions: Device: High dose rapamycin stent; Device: Low dose rapamycin stent
Sponsors: Shenyang Northern Hospital; Shenyang Northern Hospital
Recruiting - verified October 2010 - Conditions: Acute Coronary Syndrome; Acute Chest Pain
Intervention: Radiation: Cardiac CT
Sponsors: Erasmus Medical Center; Erasmus Medical Center
Recruiting - verified August 2011 - Conditions: Acute Myocardial Infarction; Heart Attack; Acute Coronary Syndrome; Unstable Angina
Intervention:
Sponsors: Yale University; Yale University
Recruiting - verified July 2011 - Condition: Chronic Stable Angina
Interventions: Drug: Nicorandil; Drug: Atenolol
Sponsors: Ferozsons Laboratories Ltd.; Ferozsons Laboratories Ltd.
Recruiting - verified December 2011 - Condition: Acute Coronary Syndrome
Intervention: Other: Genotyping and platelet reactivity testing with the VerifyNow P2Y12 assay
Sponsors: Medstar Research Institute; Medstar Research Institute
Recruiting - verified March 2012 - Conditions: Stable Angina; Coronary Disease
Interventions: Drug: Nicorandil; Drug: basic treatment
Sponsors: Merck KGaA; Merck KGaA; Merck Serono Co., Ltd., China
Recruiting - verified January 2012 - Conditions: Coronary Artery Disease; Atherosclerosis; Acute Coronary Syndrome (ACS); Myocardial Infarction (MI)
Intervention: Device: PTCA with stent placement
Sponsors: OrbusNeich; OrbusNeich; Genae associates
Recruiting - verified January 2012 - Condition: Stable Angina
Interventions: Device: Endothelial cell capture stent with 1 month clopidogrel; Device: Everolimus eluting stent with 12 month clopidogrel; Drug: Atorvastatin 20mg loading; Drug: Atorvastatin 80mg loading
Sponsors: Yonsei University; Yonsei University; OrbusNeich; Yuhan Corporation
Not yet recruiting - verified March 2012 - Condition: Acute Coronary Syndrome
Intervention: Behavioral: quality improvement initiatives
Sponsors: The George Institute for Global Health, China; The George Institute for Global Health, China
Not yet recruiting - verified July 2011 - Conditions: Risk Factor Reduction; Lifestyle Changes
Interventions: Other: rehabilitation+telephonic coaching; Other: OPTICARE-B; Other: OPTICARE-C
Sponsors: Erasmus Medical Center; Erasmus Medical Center
Recruiting - verified March 2012 - Conditions: Angina Pectoris; Chest Pain
Interventions: Other: Cardiac CT; Other: Standard care
Sponsors: Erasmus Medical Center; Erasmus Medical Center
Recruiting - verified July 2011 - Condition: Acute Coronary Syndrome
Intervention:
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris; Ministry of Health, France
Recruiting - verified July 2011 - Condition: Acute Coronary Syndrome
Intervention:
Sponsors: University Hospital, Toulouse; University Hospital, Toulouse
Recruiting - verified April 2012 - Conditions: Vascular Disease; Hypertension; Angina; Cardiac Disease
Interventions: Drug: Esmolol; Drug: Metoprolol
Sponsors: University Health Network, Toronto; University Health Network, Toronto; Baxter Healthcare Corporation
Recruiting - verified August 2011 - Condition: Acute Coronary Syndrome
Intervention: Drug: GIK solution
Sponsors: Yonsei University; Yonsei University
Recruiting - verified February 2012 - Conditions: Chest Pain; Angina; Angina Pectoris; Coronary Artery Disease
Interventions: Procedure: Stress Echocardiography; Procedure: Coronary CT Angiography
Sponsors: Montefiore Medical Center; Montefiore Medical Center; American Heart Association
Recruiting - verified September 2011 - Conditions: Myocardial Infarction; Unstable Angina
Interventions: Drug: Atorvastatin; Drug: Statin
Sponsors: Xijing Hospital; Xijing Hospital
Recruiting - verified July 2010 - Condition: ST Elevation (STEMI) Myocardial Infarction
Interventions: Drug: Rosuvastatin 40 mg; Drug: Simvastatin
Sponsors: Helse Stavanger HF; Helse Stavanger HF; Helse Vest; University Hospital of North Norway; St. Olavs Hospital
Not yet recruiting - verified August 2011 - Conditions: Lung Neoplasms; Respiratory Failure; Pneumonia; Acute Coronary Syndromes; Unstable Angina; Myocardial Infarction; Cardiac Arrhythmia; Thromboembolic Disease
Interventions: Other: Normal Saline; Other: Sodium Bicarbonate
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified April 2012 - Condition: Acute Coronary Syndrome
Intervention:
Sponsors: University of Lausanne Hospitals; University of Lausanne Hospitals
Recruiting - verified April 2011 - Condition: Acute Coronary Syndrome
Intervention:
Sponsors: University of Erlangen-Nürnberg Medical School; University of Erlangen-Nürnberg Medical School; Klinikum Nürnberg
Recruiting - verified June 2011 - Conditions: Coronary Heart Disease; Atrial Fibrillation; Acute Coronary Syndrome; Atherosclerosis
Interventions: Drug: Dabigatran; Drug: Phenprocoumon
Sponsors: Deutsches Herzzentrum Muenchen; Deutsches Herzzentrum Muenchen
Recruiting - verified April 2012 - Condition: Acute Coronary Syndrome
Interventions: Drug: Prasugrel; Drug: Prasugrel
Sponsors: Medstar Research Institute; Medstar Research Institute
Recruiting - verified February 2012 - Conditions: Obesity; Morbid Obesity; Venous Thromboembolism; Atrial Fibrillation; Angina; Chest Pain
Intervention: Drug: Lean Body Weight-based heparin dose
Sponsors: Nazareth Hospital; Nazareth Hospital
Recruiting - verified August 2011 - Condition: Microvascular Coronary Dysfunction (MCD)
Interventions: Drug: Ranolazine; Drug: Placebo
Sponsors: Cedars-Sinai Medical Center; Cedars-Sinai Medical Center; University of Florida
Recruiting - verified March 2012 - Conditions: Acute Coronary Syndrome; Anemia
Interventions: Other: RBC transfusion; Other: Normal saline infusion
Sponsors: Beth Israel Deaconess Medical Center; Beth Israel Deaconess Medical Center; American Heart Association
Recruiting - verified January 2012 - Condition: Angina
Intervention: Procedure: shockwave treatment
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center; Medispec ltd.
Recruiting - verified July 2011 - Conditions: Cardiovascular Disease; Acute Coronary Syndrome
Interventions: Drug: Prasugrel; Drug: Plavix
Sponsors: Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; University Hospital Tuebingen
Recruiting - verified May 2012 - Conditions: Diabetic Stable Angina; Diabetic Unstable Angina
Intervention: Drug: Pioglitazone
Sponsors: Korea University Anam Hospital; Korea University Anam Hospital
Recruiting - verified April 2012 - Conditions: Stable Angina Pectoris; Atherosclerosis
Interventions: Drug: Coruno; Drug: Placebo
Sponsors: Therabel Pharma SA/NV; Therabel Pharma SA/NV
Recruiting - verified May 2012 - Condition: Acute Coronary Syndrome
Intervention:
Sponsors: G. d'Annunzio University; Prof. Raffaele De Caterina; San Giovanni Addolorata Hospital
Recruiting - verified April 2011 - Conditions: Acute Coronary Syndrome; Angina Pectoris; Angina, Unstable; Myocardial Infarction; Coronary Artery Disease; Coronary Stenosis; Coronary Restenosis
Interventions: Device: Resolute Integrity (Zotarolimus-eluting stent); Device: Promus Element (Everolimus-eluting stent)
Sponsors: Cardio Research Enschede BV; Cardio Research Enschede BV
Recruiting - verified March 2012 - Conditions: Acute Coronary Syndrome; Obstructive Sleep Apnea
Interventions: Other: Standard care; Device: continuous positive airway pressure; Other: Reference
Sponsors: Sociedad Española de Neumología y Cirugía Torácica; Sociedad Española de Neumología y Cirugía Torácica; ResMed; Fondo de Investigacion Sanitaria; Esteve-Teijin; Fundacion RESPIRA; Societat Catalana de Cardiologia; Sociedad Madrileña de Neumologia
Recruiting - verified April 2011 - Condition: Acute Coronary Syndrome
Interventions: Drug: Placebo; Drug: St. Johns Wort
Sponsors: Lancaster General Hospital; Lancaster General Hospital; H. G. Barsumian Memorial Fund; Louise von Hess Medical Research Institute
Recruiting - verified January 2012 - Condition: Coronary Heart Disease
Interventions: Drug: dalcetrapib; Drug: placebo
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified October 2011 - Condition: Acute Coronary Syndrome
Intervention:
Sponsors: Luzerner Kantonsspital; Luzerner Kantonsspital; University of Zurich; University Hospital, Geneva; University Hospital Inselspital, Berne; University Hospital, Basel, Switzerland; Triemli Hospital; Kantonsspital Baden; Cantonal Hospital of St. Gallen; University Hospital Freiburg; Cantonal Hospital, Frauenfeld; Hospital Centre Biel/Bienne; Spital Lachen AG; Cardiocentro Ticino
Recruiting - verified June 2011 - Condition: Atherosclerosis
Intervention: Other: blood sample
Sponsors: Centre Hospitalier Universitaire de Saint Etienne; Centre Hospitalier Universitaire de Saint Etienne
Recruiting - verified May 2012 - Conditions: Angina; Chest Pain
Intervention: Other: Cardiac MRI
Sponsors: Piedmont Healthcare; Piedmont Healthcare; Cardiogenesis Corporation
Recruiting - verified June 2011 - Condition: Acute Coronary Syndrome
Intervention:
Sponsors: McGill University Health Center; McGill University Health Center; McGill University
Recruiting - verified September 2011 - Conditions: Coronary Heart Disease; Myocardial Infarction
Interventions: Other: Titration of medications; Behavioral: Lifestyle Counseling; Behavioral: Medication Counseling; Other: Usual Care with Medication Reconciliation
Sponsors: Middle Tennessee Research Institute; Middle Tennessee Research Institute; American Society of Health-System Pharmacists Research and Education Foundation
Recruiting - verified August 2011 - Conditions: Chest Pain; Stable Angina Pectoris, CCS Class I to III; Angina Equivalent; Coronary Artery Disease
Interventions: Device: CCTA; Device: SPECT MPI/ICA
Sponsors: American College of Radiology Imaging Network; American College of Radiology Imaging Network
Recruiting - verified April 2012 - Condition: Coronary Heart Disease
Intervention:
Sponsors: Oslo University Hospital; Oslo University Hospital
Recruiting - verified May 2012 - Condition: Chronic Stable Angina
Intervention: Drug: green tea polyphenols (STA-2)
Sponsors: Sinphar Pharmaceutical Co., Ltd; Sinphar Pharmaceutical Co., Ltd
Recruiting - verified August 2011 - Conditions: Acute Coronary Syndrome; Angioplasty, Transluminal, Percutaneous Coronary; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Blood Platelets
Interventions: Drug: rosuvastatin; Drug: placebo
Sponsors: University of Kentucky; University of Kentucky
Recruiting - verified March 2012 - Conditions: Acute Coronary Syndrome; Myocardial Infarction
Intervention:
Sponsors: Institute of Cardiology, Warsaw, Poland; Institute of Cardiology, Warsaw, Poland
Recruiting - verified November 2010 - Conditions: Hypertrophic Cardiomyopathy; Acute Coronary Syndrome
Intervention: Other: Nuclear imaging of the heart using 99mTc-NC100692
Sponsors: University of Ottawa Heart Institute; University of Ottawa Heart Institute
Recruiting - verified January 2012 - Condition: Acute Coronary Syndromes
Intervention:
Sponsors: San Filippo Neri General Hospital; San Filippo Neri General Hospital; Associazione Nazionale Medici Cardiologi Ospedalieri, Sezione Lazio
Recruiting - verified September 2010 - Condition: Refractory Angina
Interventions: Device: Neovasc Reducer; Device: Control
Sponsors: Neovasc Inc.; Neovasc Inc.
Recruiting - verified February 2012 - Condition: Acute Coronary Syndrome
Interventions: Behavioral: Community Health Worker, VITA Tool; Other: No intervention
Sponsors: St. John's Research Institute; St. John's Research Institute; National Heart and Lung Institute
Not yet recruiting - verified July 2011 - Condition: Acute Coronary Syndrome
Interventions: Drug: Placebo; Drug: CER-001
Sponsors: Cerenis Therapeutics, SA; Cerenis Therapeutics, SA
Recruiting - verified May 2012 - Conditions: Acute Coronary Syndrome; STEMI; NSTEMI; Unstable Angina; Chest Pain
Intervention:
Sponsors: Soroka University Medical Center; ori galante; BSP Biological Signal Processing Ltd.
Recruiting - verified March 2012 - Conditions: Angina; Right Ventricular Ischemia; Pulmonary Arterial Hypertension
Intervention: Drug: Ranolazine
Sponsors: Northwestern University; Northwestern University; Gilead Sciences
Recruiting - verified September 2011 - Conditions: Acute Coronary Syndrome; Coronary Stent Occlusion; Surgery
Intervention:
Sponsors: Corporacion Parc Tauli; Corporacion Parc Tauli
Recruiting - verified December 2009 - Conditions: Chest Pain; Coronary Artery Disease; Acute Coronary Syndrome
Intervention:
Sponsors: Technion, Israel Institute of Technology; Technion, Israel Institute of Technology
Recruiting - verified April 2012 - Conditions: Atherosclerosis; Coronary Artery Disease; Acute Coronary Syndrome
Interventions: Device: Coronary intervention using IVUS-VH & FDG PET-MDCT; Device: Coronary intervention using IVUS-VH & FDG PET-MDCT
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris; Institut National de la Santé Et de la Recherche Médicale, France
Recruiting - verified June 2009 - Conditions: Atherosclerosis; Percutaneous Coronary Intervention; Acute Coronary Syndrome
Interventions: Drug: cangrelor P2Y12 (platelet) inhibitor; Drug: Clopidogrel
Sponsors: The Medicines Company; The Medicines Company
Recruiting - verified September 2011 - Conditions: Acute Coronary Syndrome; ST Elevation Myocardial Infarction; Percutaneous Coronary Intervention
Intervention: Procedure: Percutaneous Coronary Intervention with or without manual aspiration thrombectomy
Sponsors: Population Health Research Institute; Population Health Research Institute
Recruiting - verified March 2012 - Condition: Acute Coronary Syndrome
Interventions: Drug: lixisenatide (AVE0010); Drug: placebo
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012 - Condition: Acute Coronary Syndrome
Intervention:
Sponsors: R&D Cardiologie; R&D Cardiologie; Sanofi-Aventis; Novartis
Recruiting - verified July 2011 - Conditions: Chest Pain; Acute Coronary Syndrome; Acute Myocardial Infarction
Interventions: Device: Observational Measurement of T-wave Alternans; Device: T-wave Alternans
Sponsors: Loma Linda University; Loma Linda University
Recruiting - verified June 2011 - Conditions: Coronary Artery Disease; Acute Coronary Syndrome; Genetic Resistance to Clopidogrel; Compliance to Thienopyridine Treatment
Intervention:
Sponsors: Biotronik France; Biotronik France; European Cardiovascular Research Center; ACTION - Allies in Cardiovascular Trials Initiatives and Organized Network
Recruiting - verified July 2011 - Conditions: Coronary Artery Disease; Angina Pectoris; Unstable Angina; Acute Coronary Syndrome
Interventions: Procedure: Coronary CT angiography; Procedure: Myocardial perfusion imaging
Sponsors: Montefiore Medical Center; Montefiore Medical Center; Albert Einstein College of Medicine of Yeshiva University
Recruiting - verified June 2011 - Conditions: Coronary Artery Disease; Percutaneous Coronary Intervention; Acute Coronary Syndromes
Interventions: Drug: clopidogrel; Drug: Prasugrel 10 mg
Sponsors: Rigshospitalet, Denmark; Rigshospitalet, Denmark
Recruiting - verified June 2010 - Condition: Acute Coronary Syndrome
Intervention: Other: biological parameters dosage
Sponsors: Nantes University Hospital; Nantes University Hospital
Recruiting - verified January 2012 - Condition: Acute Coronary Syndrome
Intervention: Drug: ADP receptor inhibitors
Sponsors: Eli Lilly and Company; Eli Lilly and Company; Daiichi Sankyo Inc.
Recruiting - verified April 2012 - Condition: ST Segment Elevation Acute Coronary Syndrome
Interventions: Drug: Bivalirudin; Drug: Heparin
Sponsors: The Medicines Company; The Medicines Company
Recruiting - verified October 2011 - Condition: Acute Coronary Syndrome
Interventions: Drug: Otamixaban (XRP0673); Drug: Otamixaban matching placebo; Drug: Unfractionated Heparin; Drug: Unfractionated Heparin matching placebo; Drug: Eptifibatide; Drug: Eptifibatide matching placebo
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012 - Condition: Acute Coronary Syndrome
Intervention:
Sponsors: University Hospital, Geneva; University Hospital, Geneva
Recruiting - verified October 2011 - Conditions: Acute Coronary Syndrome; Pulmonary Embolism
Interventions: Device: Pilot Phase; Device: Intervention group, receive the numeric PTP estimate; Device: No Intervention
Sponsors: Carolinas Healthcare System; Carolinas Healthcare System; Agency for Healthcare Research and Quality (AHRQ)
Recruiting - verified July 2011 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Aleglitazar; Drug: Placebo
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified March 2012 - Condition: Acute Chest Syndrome
Intervention:
Sponsors: Wolfson Medical Center; Wolfson Medical Center
Recruiting - verified June 2011 - Condition: Acute Coronary Syndrome
Interventions: Drug: Atorvastatin; Drug: Atorvastatin
Sponsors: Shanghai Jiao Tong University School of Medicine; Shanghai Jiao Tong University School of Medicine
Recruiting - verified February 2011 - Condition: Acute Coronary Syndromes
Interventions: Drug: Placebo; Drug: Prasugrel
Sponsors: Eli Lilly and Company; Eli Lilly and Company; Daiichi Sankyo Co., Ltd.
Recruiting - verified April 2012 - Conditions: Angina Pectoris; Myocardial Infarction
Intervention: Biological: VEGF-D gene transfer
Sponsors: Kuopio University Hospital; Kuopio University Hospital; University of Eastern Finland
Recruiting - verified January 2012 - Condition: Myocardial Ischemia
Intervention: Genetic: VM202
Sponsors: ViroMed Co., Ltd.; ViroMed Co., Ltd.; VM Biopharma
Not yet recruiting - verified February 2012 - Condition: Acute Coronary Syndrome
Interventions: Procedure: Percutaneous coronary intervention; Procedure: Intravascular ultrasound with virtual histology; Drug: Atorvastatin; Device: LDL-apheresis
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified March 2012 - Condition: Acute Coronary Syndromes
Intervention:
Sponsors: University of Zurich; University of Zurich; University of Bern; University Hospital, Geneva; University of Lausanne Hospitals
Recruiting - verified February 2012 - Conditions: Diabetes Mellitus, Type 2; Acute Coronary Syndrome
Interventions: Drug: Alogliptin; Drug: Placebo
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.
Recruiting - verified March 2012 - Conditions: Acute Coronary Syndrome; Chest Pain
Intervention:
Sponsors: William Beaumont Hospitals; William Beaumont Hospitals
Recruiting - verified March 2012 - Condition: Acute Coronary Syndrome
Interventions: Drug: Acetylsalicylic acid (Aspirin, BAY 81-8781); Drug: Acetylsalicylic acid (Aspirin, BAY 81-8781); Drug: Acetylsalicylic acid (Aspirin, BAY 81-8781)
Sponsors: Bayer; Bayer
Recruiting - verified April 2012 - Condition: Acute Coronary Syndrome
Interventions: Drug: GW856553; Drug: GW856553; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified November 2011 - Condition: Acute Coronary Syndrome
Interventions: Behavioral: Intervention; Behavioral: Usual care
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified March 2012 - Conditions: Coronary Artery Disease; Acute Coronary Syndrome; Diabetes; Metabolic Syndrome
Intervention:
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified June 2011 - Conditions: Coronary Artery Disease; Acute Coronary Syndrome
Intervention:
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified June 2011 - Condition: Chest Pain
Interventions: Procedure: CCTA; Other: Control section
Sponsors: University of Michigan; University of Michigan
Recruiting - verified August 2011 - Conditions: Angina Pectoris; Left Ventricular Wall Motion Abnormalities
Intervention: Procedure: 2D-strain echo
Sponsors: RWTH Aachen University; RWTH Aachen University
Recruiting - verified March 2012 - Conditions: Myocardial Infarction; Angina; Coronary Artery Disease; Myocardial Ischemia
Intervention: Device: Intravascular Near Infrared Spectroscopy
Sponsors: InfraReDx; InfraReDx
Recruiting - verified March 2012 - Conditions: Coronary Heart Disease; Acute Coronary Syndrome; Impaired Glucose Tolerance; Type 2 Diabetes Mellitus (T2DM)
Interventions: Drug: Acarbose; Drug: Matching Placebo
Sponsors: University of Oxford; University of Oxford; Bayer
Recruiting - verified September 2011 - Condition: Acute Coronary Syndromes
Interventions: Procedure: Intravascular ultrasound; Procedure: MRI
Sponsors: New York University School of Medicine; New York University School of Medicine; Doris Duke Charitable Foundation
Recruiting - verified December 2011 - Condition: Acute Myocardial Infarction
Intervention: Drug: Adenosine
Sponsors: Hospital Universitari Vall d'Hebron Research Institute; David Garcia-Dorado; Hospital General Universitario Gregorio Marañon; Hospital Clinico Universitario de Valladolid; Hospital Universitario Virgen de la Macarena; Instituto de Ciencias del Corazon
Recruiting - verified March 2012 - Conditions: Acute Myocardial Infarction (AMI); Coronary Occlusion; Acute Coronary Syndrome
Intervention: Device: AngelMed Guardian System
Sponsors: Angel Medical Systems; Angel Medical Systems; Symbios Clinical
Recruiting - verified April 2012 - Condition: Type 2 Diabetes
Interventions: Drug: aspirin; Drug: aspirin
Sponsors: University of Vigo; University of Vigo
Recruiting - verified March 2012 - Conditions: Cancer; Thrombosis; Angina Pectoris; Advanced Solid Malignancy
Intervention:
Sponsors: Shaare Zedek Medical Center; Shaare Zedek Medical Center
Recruiting - verified February 2009 - Conditions: Coronary Artery Disease; Acute Myocardial Infarction
Interventions: Biological: autologous bone marrow-derived progenitor cells; Biological: placebo medium
Sponsors: Johann Wolfgang Goethe University Hospitals; Johann Wolfgang Goethe University Hospitals; University of Leipzig
Recruiting - verified May 2010 - Conditions: Coronary Artery Disease; Acute Coronary Syndrome
Interventions: Device: drug-eluting stent; Drug: Tirofiban
Sponsors: Shanghai Jiao Tong University School of Medicine; Shanghai Jiao Tong University School of Medicine; Ministry of Science and Technology of the People´s Republic of China; Changhai Hospital
Recruiting - verified January 2011 - Conditions: Coronary Artery Disease; Angina Pectoris; Unstable Angina; Acute Coronary Syndrome
Interventions: Procedure: Coronary Computed Tomography Angiography; Procedure: Stress Nuclear Myocardial Perfusion Imaging
Sponsors: Montefiore Medical Center; Montefiore Medical Center; American Heart Association; Albert Einstein College of Medicine of Yeshiva University
Recruiting - verified June 2011 - Condition: Refractory Angina Pectoris
Interventions: Device: Cardiac Extracorporeal Shockwave Therapy generator (Cardiospec); Device: Placebo
Sponsors: Medispec; Medispec; Hadassah Medical Organization
Recruiting - verified March 2012 - Conditions: Myocardial Infarction; Angina, Unstable
Intervention:
Sponsors: University Hospital, Basel, Switzerland; University Hospital, Basel, Switzerland; Swiss National Science Foundation
Recruiting - verified May 2011 - Conditions: Depressive Disorder; Coronary Disease
Interventions: Drug: Escitalopram; Drug: Placebo
Sponsors: Chonnam National University Hospital; Chonnam National University Hospital; H. Lundbeck A/S
Recruiting - verified July 2009 - Conditions: Acute Coronary Syndrome; Venous Thromboembolism; Atrial Fibrillation; Hypercoagulability
Intervention:
Sponsors: Hadassah Medical Organization; Hadassah Medical Organization
Recruiting - verified June 2011 - Conditions: Angina; Coronary Artery Disease
Intervention: Behavioral: Exercise training
Sponsors: Norwegian University of Science and Technology; Norwegian University of Science and Technology
Recruiting - verified May 2012
 |
Clinical Trials for Cardiovascular Disorders, Angina Pectoris |
